FLT4 and prostate carcinoma: The expression of VEGFR-3 has been found to be upregulated in various human malignancies, including leukemia, breast cancer, colorectal cancer, prostate cancer, renal cell carcinoma, and hepatocellular carcinoma [38, 40].